Our clinical trial portal now includes the following study: Eslicarbazepine Acetate (ESL) as an Add-On Therapy in Partial Onset Seizures.
Learn more about participating: http://bit.ly/2tF6ZGH
Visit the Clinical Trials Portal: epilepsy.com/clinical_trials